Company profileMixed portfolio#98 of 1,318 in Pakistan1 DRAP alert

Elite Pharma (Pvt) Ltd

Mixed portfolio · 42 pharmaceutical brands of 164 registrations

Ranked #1 of 3 companies in Other Cardiac Preparations

164 registered products 42 pharmaceutical brands 118 distinct molecules 1 DRAP alert
Part of this company's portfolio (“Nutritional Supplement / Multivitamin”) is registered under a broad DRAP category rather than distinct molecules, so the molecule count understates its true range.

Company overview

164
registered products
42
pharmaceutical brands
118
distinct molecules
5
therapeutic classes
1
DRAP alerts

Elite Pharma (Pvt) Ltd is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 164 product registrations across 118 distinct molecules. It is the 98th largest registrant in Pakistan by product count, and ranks 1st of 3 in Other Cardiac Preparations. Its portfolio is concentrated in Other Cardiac Preparations and Pain Management. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Elite

40 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

39
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202539

Top molecules by brand count

Nutritional Supplement / Multivitamin66 brands
Amoxicillin8 brands
Lignocaine7 brands
Cefixime4 brands
Ketamine3 brands
Adrenaline3 brands
Amoxicillin ...... 125 Mg2 brands
Amikacin2 brands
Ephedrine2 brands

Therapeutic classes

Other Cardiac Preparations · 1Pain Management · 1Anaesthetic, Local · 1Antiglaucoma Preparations And Miotics · 1Allergy · 1

Conditions treated

Anaphylaxis Shock/Burn/Oedema · 1Anaesthesia · 1Conventional Agents · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official75 products · Rs 3.19 – Rs 2,059.06
Servaid3 products · Rs 10 – Rs 67
Median across source: Rs 237.45

Regulatory record

1 alert in the DRAP feed we track.

26. Recall Alert (Human) – DTLs Punjab declared Substandard products
2026-05-04

Competitive set

Companies whose registered portfolio overlaps most with this one.

NEUTRO PHARMA (PVT) LTD.32 shared molecules
IRZA PHARMA (PVT) LTD.27 shared molecules
BIO LABS (PVT) LTD.27 shared molecules
EPHARM LABORATORIES26 shared molecules
VENUS PHARMA24 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NEUTRO PHARMA (PVT) LTD. holds 116 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAnastrazoleAnastrozoleAntimony
SIZA INTERNATIONAL (PVT) LTD. holds 77 molecules not in this portfolio
AcyclovirAlbendazoleAlbuterolAllopurinolAllopurinol TabAmitriptyline
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 143 molecules not in this portfolio
AlbuterolAminophyllineAmlodipineAmlodipine BaseAmmonium ChlorideAmmonium Chloride Containing Expectorants

Get the full profile for Elite

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.